Choose your country or region
Following the acquisition of ADx NeuroSciences NV by Fujirebio Europe NV in 2022, the merger will officially take effect on 1 April 2026.
What does this mean for ADx NeuroSciences NV customers?
All operations will be conducted under the name Fujirebio Europe NV.
Our commitment to deliver high-quality products and services remain unchanged. The integration of our teams allows us to better support you with an expanded portfolio and a broader range of expertise.
Choose your country or region